 |
 |

Amantadine in Parkinson's DiseaseReview of More Than Two Years' Experience
Robert S. Schwab, MD;
David C. Poskanzer, MD;
Albert C. England, Jr., MD;
Robert R. Young, MD
JAMA. 1972;222(7):792-795.
Abstract
Four hundred thirty patients with Parkinson's disease were treated with amantadine hydrochloride alone or in conjunction with other anti-Parkinsonism medications over a 2 1/2-year period. Of 351 patients who took 200 mg a day for 60 days, 64% showed a favorable response to the drug at 60 days and thereafter. Of those patients who received amantadine and levodopa, 79% responded favorably, as compared with 48% in the group who did not receive levodopa. In one half of the patients treated, a decline in the therapeutic efficacy of amantadine was observed between 30 and 60 days. Few side effects were noted even after long periods of administration, and laboratory studies disclosed no consistent significant abnormalities.
Author Affiliations
From the Parkinson's Disease Project and Neurology Service, Massachusetts General Hospital, and Department of Neurology, Harvard Medical School, Boston.; Dr. Schwab died April 6, 1972.
Footnotes
Reprint requests to Department of Neurology, Massachusetts General Hospital, Boston 02114 (Dr. Poskanzer).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Amantadine inhibits platelet-activating factor induced clathrin-mediated endocytosis in human neutrophils
Eckels et al.
Am. J. Physiol. Cell Physiol. 2009;297:C886-C897.
ABSTRACT
| FULL TEXT
An algorithm (decision tree) for the management of Parkinson's disease (2001):: Treatment
Olanow et al.
Neurology 2001;56:S1-S88.
FULL TEXT
Amantadine for Levodopa-Induced Dyskinesias: A 1-Year Follow-up Study
Metman et al.
Arch Neurol 1999;56:1383-1386.
ABSTRACT
| FULL TEXT
Amantadine Inhibits Nicotinic Acetylcholine Receptor Function in Hippocampal Neurons
Matsubayashi et al.
J. Pharmacol. Exp. Ther. 1997;281:834-844.
ABSTRACT
| FULL TEXT
Prevention of Russian Influenza by Amantadine
Monto et al.
JAMA 1979;241:1003-1007.
ABSTRACT
Control of Influenza in the Hospital
HOFFMAN and DIXON
ANN INTERN MED 1977;87:725-728.
ABSTRACT
Prevention and Control of Influenza by Chemoprophylaxis and Chemotherapy: Prospects From Examination of Recent Experience
Jackson and Stanley
JAMA 1976;235:2739-2742.
ABSTRACT
|